Heng T Duong, MD
Pulmonary Disease · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 4 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
11 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Duong’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A128595 · Current
Licensed to practise in California · since 2014 · expires 2027-04-30 · Case Western Reserve University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Illinois 036137335Licensed Physician And Surgeon · since 2015 · expires 2020-09-30Not RenewedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$48,163
Medicare paid this office $48,163 for 194 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 64 | $30,225 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $3,092 | $107 |
| Return visit (30+ min) | 30 | $2,827 | $86 |
| Short return visit (20+ min) | 41 | $2,408 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,228 | $117 |
See all 10 services
| Critical care, first 30-74 minutes | 64 | $30,225 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $3,092 | $107 |
| Return visit (30+ min) | 30 | $2,827 | $86 |
| Short return visit (20+ min) | 41 | $2,408 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,228 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,842 | $71 |
| New patient visit (45+ min) | 12 | $1,441 | $120 |
| Test to determine lung volumes using sensors | 18 | $181 | $10 |
| Test to examine how well the lungs exchange gases | 13 | $94 | $7 |
| Test to measure expiratory airflow and volume | 12 | $87 | $7 |
Who their Medicare patients are
194 Original Medicare patients in 2024. Average age 72 · Under 65 17% · 85 and older 16% · Women 50% · Also on Medicaid 79% · Health risk score 3.18. Above the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 75% · Diabetes 57% · Heart failure 46% · Chronic kidney disease 44% · COPD 41% · Coronary heart disease 33% · Atrial fibrillation 31% · Depression 27% · Dementia 23% · Stroke 23% · Cancer 21%.
The office billed $516,649, Medicare allowed $62,020 and paid $48,163; for 425 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 194 | 425 | 72 | 3.18 | $516,649 | $48,163 |
| 2023 | 197 | 378 | 71 | 2.95 | $408,639 | $42,110 |
| 2022 | 204 | 475 | 71 | 2.60 | $567,156 | $64,398 |
| 2021 | 169 | 357 | 70 | 2.18 | $410,063 | $49,862 |
| 2020 | 212 | 536 | 70 | 2.72 | $650,998 | $81,562 |
| 2019 | 120 | 225 | 70 | 2.41 | $238,067 | $26,187 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Critical care, first 30-74 minutes | 50 | $24,015 | $197 |
| Short return visit (20+ min) | 69 | $4,331 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $3,101 | $76 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,578 | $112 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,509 | $119 |
| Return visit (30+ min) | 26 | $1,897 | $70 |
2022: 6 services
| Critical care, first 30-74 minutes | 63 | $43,930 | $224 |
| Short return visit (20+ min) | 80 | $5,559 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $4,781 | $114 |
| Return visit (30+ min) | 21 | $1,931 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,768 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,733 | $133 |
2021: 7 services
| Critical care, first 30-74 minutes | 53 | $35,313 | $224 |
| Short return visit (20+ min) | 45 | $3,218 | $62 |
| Return visit (30+ min) | 22 | $2,090 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,775 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,766 | $118 |
| Telephone medical discussion with physician, 21-30 minutes | 18 | $1,667 | $93 |
| Telephone medical discussion with physician, 5-10 minutes | 15 | $503 | $31 |
2020: 6 services
| Critical care, first 30-74 minutes | 78 | $67,759 | $234 |
| Telephone medical discussion with physician, 11-20 minutes | 56 | $3,135 | $47 |
| Short return visit (20+ min) | 46 | $2,264 | $41 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $2,088 | $80 |
| Return visit (30+ min) | 19 | $1,240 | $65 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $739 | $62 |
2019: 3 services
| Critical care, first 30-74 minutes | 40 | $19,321 | $195 |
| Short return visit (20+ min) | 42 | $2,105 | $45 |
| Return visit (30+ min) | 12 | $849 | $71 |
Medicaid work
$11,780 in 2024
Medicaid paid $11,780 for 580 billed services this clinician did in 2024, up to 25 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 217 | $10,853 |
| Short return visit (20+ min) | 70 | $653 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 19 | $135 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 38 | $68 |
| Diffusing capacity | 38 | $44 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 22 | $27 |
| Medication list documented in medical record (COA) | 97 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 15 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 64 | $0 |
| 2024 | 580 | 9 | 25 | $11,780 |
| 2023 | 487 | 8 | 33 | $6,838 |
| 2022 | 237 | 2 | 29 | $2,979 |
| 2021 | 306 | 2 | 24 | $10,776 |
| 2020 | 417 | 2 | 27 | $23,920 |
| 2019 | 274 | 5 | 31 | $10,485 |
See the largest Medicaid services in earlier years
2023
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 208 | $6,052 |
| Short return visit (20+ min) | 181 | $619 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 15 | $150 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 12 | $18 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 12 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 13 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 33 | $0 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 13 | $0 |
2022
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 47 | $2,088 |
| Short return visit (20+ min) | 190 | $892 |
2021
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 201 | $10,307 |
| Short return visit (20+ min) | 105 | $469 |
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 371 | $23,687 |
| Short return visit (20+ min) | 46 | $233 |
2019
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 183 | $10,359 |
| Short return visit (20+ min) | 46 | $127 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 15 | $0 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 15 | $0 |
| Diffusing capacity | 15 | $0 |
Drugs they prescribed that Part D paid
$551,100
Pharmacies billed $551,100 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 543) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.
186 generic and 357 brand-name prescriptions · $551,100 in drug cost · 15 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ambrisentan | 27 | $215,622 | $7,986 |
| Ofev | 13 | $158,675 | $12,206 |
| Nucala | 11 | $37,427 | $3,402 |
| Spiriva Respimat | 33 | $23,234 | $704 |
| Spiriva Handihaler | 35 | $20,579 | $588 |
See all 18 drugs
| Ambrisentan | 27 | $215,622 | $7,986 |
| Ofev | 13 | $158,675 | $12,206 |
| Nucala | 11 | $37,427 | $3,402 |
| Spiriva Respimat | 33 | $23,234 | $704 |
| Spiriva Handihaler | 35 | $20,579 | $588 |
| Breo Ellipta | 45 | $20,357 | $452 |
| Anoro Ellipta | 24 | $10,319 | $430 |
| Incruse Ellipta | 29 | $9,362 | $323 |
| Atrovent Hfa | 18 | $8,680 | $482 |
| Budesonide-Formoterol | 19 | $4,429 | $233 |
| Wixela Inhub | 22 | $2,838 | $129 |
| Symbicort | 11 | $2,353 | $214 |
| Albuterol Sulfate Hfa | 56 | $2,312 | $41 |
| Ventolin Hfa | 15 | $835 | $56 |
| Azithromycin | 12 | $278 | $23 |
| Montelukast | 19 | $249 | $13 |
| Fluticasone Propionate | 29 | $182 | $6 |
| Prednisone | 11 | $66 | $6 |
Year by year
| 2024 | 543 | 115 | 0% (0) | 66% | $551,100 |
| 2023 | 524 | 92 | 0% (0) | 68% | $489,644 |
| 2022 | 596 | 105 | 0% (0) | 68% | $511,743 |
| 2021 | 509 | 94 | 0% (0) | 68% | $393,766 |
| 2020 | 363 | 85 | 0% (0) | 72% | $172,016 |
| 2019 | 86 | 39 | 0% (0) | 57% | $16,789 |
| 2018 | 39 | 12 | 0% (0) | 79% | $10,588 |
| 2017 | 192 | 30 | 0% (0) | 68% | $44,673 |
| 2016 | 134 | 27 | 0% (0) | 70% | $27,541 |
| 2015 | 24 | 13 | 0% (0) | None | $2,347 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Ofev | 15 | $194,463 | $12,964 |
| Ambrisentan | 12 | $119,132 | $9,928 |
| Symbicort | 67 | $29,422 | $439 |
| Spiriva Handihaler | 37 | $23,183 | $627 |
| Advair Diskus | 48 | $21,748 | $453 |
| Breo Ellipta | 23 | $11,536 | $502 |
| Spiriva Respimat | 18 | $9,856 | $548 |
| Incruse Ellipta | 19 | $7,347 | $387 |
| Anoro Ellipta | 14 | $7,000 | $500 |
| Atrovent Hfa | 11 | $4,487 | $408 |
| Wixela Inhub | 12 | $1,960 | $163 |
| Albuterol Sulfate Hfa | 46 | $1,951 | $42 |
| Ventolin Hfa | 25 | $1,575 | $63 |
| Fluticasone Propionate | 33 | $620 | $19 |
| Montelukast | 21 | $326 | $16 |
| Azithromycin | 11 | $258 | $23 |
| Prednisone | 13 | $95 | $7 |
2022: 19 drugs
| Ofev | 20 | $244,173 | $12,209 |
| Ambrisentan | 21 | $122,306 | $5,824 |
| Symbicort | 71 | $27,979 | $394 |
| Advair Diskus | 59 | $26,489 | $449 |
| Spiriva Handihaler | 35 | $24,013 | $686 |
| Anoro Ellipta | 18 | $8,691 | $483 |
| Breo Ellipta | 20 | $7,471 | $374 |
| Incruse Ellipta | 16 | $6,879 | $430 |
| Eliquis | 11 | $6,778 | $616 |
| Atrovent Hfa | 14 | $6,232 | $445 |
| Spiriva Respimat | 11 | $5,328 | $484 |
| Wixela Inhub | 21 | $4,281 | $204 |
| Albuterol Sulfate Hfa | 65 | $3,780 | $58 |
| Ventolin Hfa | 21 | $1,309 | $62 |
| Levalbuterol Tartrate Hfa | 11 | $645 | $59 |
| Fluticasone Propionate | 21 | $214 | $10 |
| Prednisone | 21 | $167 | $8 |
| Pantoprazole | 18 | $161 | $9 |
| Montelukast | 20 | $131 | $7 |
2021: 17 drugs
| Ofev | 22 | $221,452 | $10,066 |
| Advair Diskus | 66 | $34,821 | $528 |
| Spiriva | 38 | $24,772 | $652 |
| Breo Ellipta | 27 | $9,879 | $366 |
| Symbicort | 31 | $9,211 | $297 |
| Anoro Ellipta | 16 | $7,293 | $456 |
| Incruse Ellipta | 14 | $6,619 | $473 |
| Eliquis | 12 | $6,387 | $532 |
| Wixela Inhub | 18 | $6,070 | $337 |
| Spiriva Respimat | 11 | $5,126 | $466 |
| Atrovent Hfa | 12 | $4,992 | $416 |
| Albuterol Sulfate Hfa | 36 | $1,678 | $47 |
| Ventolin Hfa | 12 | $859 | $72 |
| Azithromycin | 16 | $221 | $14 |
| Montelukast | 21 | $142 | $7 |
| Fluticasone Propionate | 15 | $114 | $8 |
| Prednisone | 15 | $111 | $7 |
2020: 10 drugs
| Advair Diskus | 37 | $23,345 | $631 |
| Incruse Ellipta | 35 | $14,231 | $407 |
| Spiriva | 23 | $12,152 | $528 |
| Symbicort | 34 | $12,078 | $355 |
| Spiriva Respimat | 18 | $8,008 | $445 |
| Albuterol Sulfate Hfa | 31 | $1,334 | $43 |
| Ventolin Hfa | 16 | $950 | $59 |
| Fluticasone Propionate | 17 | $147 | $9 |
| Montelukast | 20 | $128 | $6 |
| Prednisone | 12 | $87 | $7 |
2018: 1 drug
| Spiriva | 13 | $5,348 | $411 |
2017: 8 drugs
| Symbicort | 27 | $13,035 | $483 |
| Spiriva | 30 | $12,138 | $405 |
| Incruse Ellipta | 14 | $5,625 | $402 |
| Advair Diskus | 14 | $5,382 | $384 |
| Proair Hfa | 16 | $1,003 | $63 |
| Ventolin Hfa | 14 | $879 | $63 |
| Fluticasone Propionate | 15 | $173 | $12 |
| Prednisone | 22 | $142 | $6 |
2016: 5 drugs
| Spiriva | 28 | $10,200 | $364 |
| Symbicort | 21 | $8,238 | $392 |
| Advair Diskus | 11 | $3,177 | $289 |
| Proair Hfa | 18 | $994 | $55 |
| Prednisone | 27 | $203 | $8 |
Money from drug and device companies
$22 in 2025
| 2025 | 1 | 1 | None | $22 |
| 2024 | 1 | 1 | None | $23 |
| 2023 | 1 | 2 | None | $652 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Actelion Pharmaceuticals US | Uptravi | $22 | 1 payment
|
See the published payment
| Actelion Pharmaceuticals US | Meals · 2025-05-07 | Uptravi | $22 |
See earlier years (2024, 2023)
2024: $23
| Actelion Pharmaceuticals US | Uptravi | $23 | 1 payment
|
2023: $652
| Noah Medical | None | $652 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1700142189
- Licence
- CA A128595, IL 036137335California A128595: Current · expires 2027-04-30Illinois 036137335: Not Renewed
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Internal medicine (207R00000X)
- Mailing address
- 751 S Bascom Ave, San Jose, CA, 95128
- NPI first listed
- 2012-04-10
- NPI last updated
- 2019-06-24
This is when the NPI record was last certified, not a medical board exam.